Risk Factor Analysis of Young Patients with Uveal ...
Medical Student Award – Arina Nisanova
March 31, 2026
Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...
Medical Student Award – Arina Nisanova
Uveal melanoma (UM) is the most common eye cancer in adults which originates from pigmented cells in the uvea of the eye. The major challenge in UM treatment is the high fr...
Uveal melanoma (UM) is a type of aggressive eye cancer that often spreads to the liver and has a poor prognosis. We don’t fully understand how UM spreads, which makes it ...
Description: Hybrid cells, in circulation and in the tumor are reprogrammed cancer cells displaying immune cell mimicry—insights into their impact on tumor progression, i...
UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...
Uveal melanoma (UM) is a highly aggressive eye cancer that leads to metastatic death in up to half of patients, with no measurable improvement in survival over the past hal...
Melanoma is the most aggressive form of skin cancer. Although progress has been made for advanced melanoma patients with 13 new FDA-approved therapies since 2011, resistanc...
Uveal melanoma is an aggressive cancer of the eye. There is no cure for metastatic disease, and therefore it is always fatal. Predictive tests can identify patients with ag...
A type of cancer found in the colored part the eye is called uveal melanoma. This particular type of cancer can often be treated successfully with surgery and radiation. Ho...
Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...
Uveal melanoma is a type of melanoma that occurs in the eye as opposed to the most common presentations of melanoma, which occur on the skin. A diagnosis of uveal ...
Description: Treatment of advanced melanoma with immunotherapy agents shows striking responses in some patients, however overall responses are low. In addition, a significa...
Sep 26, 2026 ET